Cranberry Supplements: Recurrent UTI Prevention, PACs and Safety

What are cranberry supplements?

Cranberry supplements usually contain fruit preparations of Vaccinium macrocarpon. Products include juice, powders and concentrated extracts. Labels may specify proanthocyanidins, often shortened to PACs, a group of plant compounds studied in relation to bacterial attachment in the urinary tract.

People usually take cranberry to reduce recurrent urinary tract infections. Researchers have also tested specific cranberry preparations for memory, blood-vessel function and suppression of a stomach bacterium. Those smaller research areas answer different questions from UTI prevention.

How have cranberries been used historically?

NCCIH's historical account^[1] describes cranberry as a food, dye and medicine among Native Americans and later European settlers. Fruit and leaves were used for complaints involving the bladder, stomach, liver and blood, as well as wounds and other conditions.

Modern supplements mostly use fruit juice, powder or extracts. The clinical studies below test particular preparations for specific outcomes.

Why do people take cranberry supplements?

Comparing amounts: no single best dose is established

As of 2026, there is no recognized recommended daily amount for cranberry. The reviewed NIH and Cochrane sources do not establish one optimal dose across cranberry products.

The extract amount and PAC amount per full daily serving measure different things. A large berry-equivalent weight does not tell you how much PAC the finished product supplies. PAC information describes composition; it does not supply a proven threshold for choosing an effective product.

Processing can make a large difference. One analysis of finished cranberry drinks^[3] measured 23.0 mg of proanthocyanidins per 100 mL in juice that was not from concentrate, versus 8.9 mg per 100 mL in juice reconstituted from concentrate—about 61% less. The study compared finished drinks, so it cannot assign that difference to one processing step. Pressing research^[4] found that removing skins and seeds was a major source of polyphenol loss from juice; those compounds can remain in the material used to make some extracts. Processing can therefore remove PACs from one product or concentrate them in another. The final serving amount matters more than the starting berry weight.

An assay measures compounds using a particular method; results from different methods are not always directly interchangeable. The Cochrane review also compared studies grouped below 40, from 40–80, and above 80 mg PAC daily. None of those pooled comparisons clearly established a benefit over placebo, and they were not direct tests of the three amounts against each other. More PAC did not emerge as a proven better regimen.

A qualified label claim described by NCCIH^[1] allows limited-evidence wording for recurrent-infection prevention in healthy women. That is a qualified prevention claim, not approval to treat an existing infection.

Juice or capsules?

Juice can be a convenient food choice, but sugar, volume and taste affect whether someone uses it consistently. Capsules can avoid the drink's volume while still varying in composition.

In the Cochrane review, six juice-or-syrup studies in 1,322 women with recurrent infections did not clearly separate from placebo or no treatment. Three smaller tablet-or-powder studies in 333 women favored cranberry. These were different sets of studies within the same review. The one direct juice-versus-tablet comparison involved only 100 women and was too imprecise to establish which form worked better.

Compare the daily preparation you would actually use. “Equivalent to thousands of milligrams of fresh fruit” does not establish equivalence to the juice or extract in a study.

Drawbacks and side effects

If you are pregnant or breastfeeding and plan to use cranberry capsules or regular juice specifically to prevent infections, ask your maternity clinician whether that product and plan are appropriate.

Who benefited in the updated review?

The 2023 Cochrane update included 50 studies and 8,857 participants across several different risk groups. Its mixed-product analysis in women with recurrent infections included eight studies and 1,555 women. The estimated risk was 180 per 1,000 with cranberry versus 243 per 1,000 in the comparison groups. The uncertainty interval for cranberry ranged from 134 to 241 per 1,000, so the size of the benefit remains uncertain. This concerns preventing symptomatic infections confirmed by urine culture during treatment. Eligible studies lasted at least one month; these pooled figures are not a uniform annual risk.

Children and people susceptible after certain medical or surgical procedures also had favorable pooled findings. They were separate populations, not additional confirmation of the women’s result. The review prints different child counts and estimates in its summary table and analysis section, so a single precise child benefit cannot be given confidently from that document.

The review did not support the same benefit in older people in institutions, pregnant women or adults with neuromuscular bladder dysfunction and incomplete bladder emptying. These differences mean that a result from one risk group should not be transferred to everyone prone to infection.

What did the prevention trials report about harms?

Ten studies involving 2,166 people reported gastrointestinal events. The review estimated about 54 per 1,000 with cranberry versus 41 per 1,000 with comparison treatments; the uncertainty interval reached from no difference to more events. Four studies reporting deaths found no clear difference, but their results were too imprecise to establish equal risk. These are pooled study-period findings, not annual rates.

Can cranberry treat symptoms that have already started?

The prevention review does not answer this question. NCCIH^[1] advises against cranberry as treatment for an existing UTI. The European Association of Urology guideline^[5] is more permissive about cranberry juice for symptom relief and recurrence prevention, while explicitly describing the evidence as low quality and contradictory. Its acute-cystitis evidence section also says the available studies are insufficient to establish whether cranberry helps.

Symptom relief, reduced antibiotic use and clearing an infection are different outcomes. A clinician can help decide whether a nonantibiotic approach is appropriate for a particular episode.

What do the memory studies show?

A 2022 feasibility trial^[6] assigned 60 healthy adults aged 50–80 to placebo or 9 g/day freeze-dried cranberry powder, approximately 100 g of fresh berries, for twelve weeks. All completed the intervention. The cranberry group improved more on a test requiring them to recall a previously seen complex figure; the other cognitive tests did not show a significant treatment effect.

MRI measurements in a smaller subset suggested greater blood flow in selected brain regions, but many follow-up scans were unavailable. The Cranberry Institute funded the study. These selective findings are preliminary evidence about a particular powder and test, not demonstrated prevention of dementia.

An earlier six-week trial^[7] assigned 50 cognitively healthy adults aged at least 60 to a daily 32-ounce beverage containing 27% cranberry juice or placebo. After adjustment for the many comparisons, it found no significant advantage on the cognitive tests. The preparation and duration differed from the powder trial, and together they leave the memory question unsettled.

Does cranberry improve blood-vessel function?

In a one-month trial of 45 healthy men^[8], 9 g/day whole-cranberry powder, equivalent to about 100 g fresh fruit, improved flow-mediated dilation compared with control powder. This measures how readily an artery widens in response to increased blood flow. Blood pressure, arterial-stiffness measures, cholesterol and blood glucose did not improve significantly.

The twelve-week memory study also reported a favorable LDL-cholesterol result, whereas the one-month vascular trial did not.

What about the stomach bacterium H. pylori?

A trial in Linqu County, China^[9] studied 522 adults with H. pylori infection. Participants received different juice or encapsulated-powder regimens, or matching placebos, for eight weeks. The higher juice regimen provided 240 mL with 44 mg PAC twice daily.

At eight weeks, the analysis including everyone assigned to those juice groups found negative breath tests in 13 of 74 people on the higher regimen versus 5 of 73 on placebo. Lower juice regimens and the tested capsules did not show the same benefit. At two weeks, the higher juice regimen had not clearly beaten placebo. The study was funded by the Cranberry Marketing Committee.

This was bacterial suppression during use. Only a small, selected subset was followed after treatment stopped, and the researchers did not statistically compare those follow-up results. A review of four randomized trials^[10] also found no statistically clear overall eradication benefit. Cranberry has not thereby been established as a replacement for an H. pylori treatment course.

What about gut microbes and oral health?

A six-week pilot in 45 adults with overweight or obesity^[11] tested two 240 mL cranberry drinks daily against matched placebo. Researchers found changes in some substances produced as the body and gut microbes process cranberry compounds, but no overall increase in the variety of gut microbes. A possible change in a bacterial group called Eggerthella was too uncertain after accounting for the many comparisons. The study did not establish relief of digestive symptoms.

A separate periodontal pilot^[12] reported 41 patients with diabetes and gum disease across four groups: dental care alone, omega-3, cranberry juice, or cranberry juice enriched with omega-3. Everyone received nonsurgical dental treatment. Some inflammatory-marker findings favored the combination, while dental measurements improved in all groups. The combination findings cannot be assigned to cranberry alone; the small study does not yet provide a dependable cranberry regimen for gum disease.

When do urinary symptoms need medical assessment?

Burning urination, urgency or a new infection pattern need clinical evaluation. Fever, flank pain, vomiting or feeling significantly unwell can indicate a more serious infection and require prompt care. Women who are pregnant should seek advice promptly for urinary symptoms.

A urine test can help diagnose the cause of urinary symptoms.

The bottom line

Cranberry can be a reasonable option to discuss for preventing recurrent infections, especially for women with repeated infections. Juice and capsules both have research behind them, but neither a best form nor an optimal PAC amount is established. Prevention is a different decision from treating symptoms already present. The memory, vascular, gastric and gut findings broaden the research picture, but remain preliminary and preparation-specific.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly